JP2024545186A5 - - Google Patents

Info

Publication number
JP2024545186A5
JP2024545186A5 JP2024534656A JP2024534656A JP2024545186A5 JP 2024545186 A5 JP2024545186 A5 JP 2024545186A5 JP 2024534656 A JP2024534656 A JP 2024534656A JP 2024534656 A JP2024534656 A JP 2024534656A JP 2024545186 A5 JP2024545186 A5 JP 2024545186A5
Authority
JP
Japan
Prior art keywords
raav
nucleic acid
sequence
promoter
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024534656A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024545186A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/081321 external-priority patent/WO2023108157A1/en
Publication of JP2024545186A publication Critical patent/JP2024545186A/ja
Publication of JP2024545186A5 publication Critical patent/JP2024545186A5/ja
Pending legal-status Critical Current

Links

JP2024534656A 2021-12-10 2022-12-09 ウイルスベクターによるmybpc3関連肥大型心筋症を処置するための方法および組成物 Pending JP2024545186A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163288519P 2021-12-10 2021-12-10
US63/288,519 2021-12-10
PCT/US2022/081321 WO2023108157A1 (en) 2021-12-10 2022-12-09 Methods and compositions for treating mybpc3 related hypertrophic cardiomyopathy with a viral vector

Publications (2)

Publication Number Publication Date
JP2024545186A JP2024545186A (ja) 2024-12-05
JP2024545186A5 true JP2024545186A5 (enExample) 2025-12-17

Family

ID=86731341

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024534656A Pending JP2024545186A (ja) 2021-12-10 2022-12-09 ウイルスベクターによるmybpc3関連肥大型心筋症を処置するための方法および組成物

Country Status (8)

Country Link
US (1) US20250041452A1 (enExample)
EP (1) EP4444363A4 (enExample)
JP (1) JP2024545186A (enExample)
KR (1) KR20240122827A (enExample)
AU (1) AU2022408189A1 (enExample)
CA (1) CA3242262A1 (enExample)
IL (1) IL313426A (enExample)
WO (1) WO2023108157A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202525313A (zh) * 2023-09-06 2025-07-01 瑞士商迪納柯公司 用aav基因治療載體及治療調配物治療肥厚性心肌病之方法
CN117959432A (zh) * 2023-12-13 2024-05-03 上海市第十人民医院 一种myl4基因在治疗或预防心房疾病中的应用
WO2025162449A1 (en) * 2024-01-30 2025-08-07 Inspirar Limited Compositions and methods for the treatment of heart disease

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6673768B1 (en) * 1997-10-16 2004-01-06 Board Of Regents, The University Of Texas System Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating)
EP2352833B1 (en) * 2008-10-01 2013-03-06 TET Systems GmbH & Co. KG Tetracycline inducible transcription control sequence
WO2017191274A2 (en) * 2016-05-04 2017-11-09 Curevac Ag Rna encoding a therapeutic protein
RU2770922C2 (ru) * 2017-09-20 2022-04-25 4Д Молекьюлар Терапьютикс Инк. Капсиды вариантов аденоассоциированных вирусов и методы их применения
CN109776680B (zh) * 2019-01-25 2020-05-12 浙江蓝盾药业有限公司 抗人pcsk9单克隆抗体及其用途
WO2021030764A1 (en) * 2019-08-14 2021-02-18 University Of Florida Research Foundation, Incorporated Aav capsid variants for gene therapy
WO2021154923A2 (en) * 2020-01-29 2021-08-05 Voyager Therapeutics, Inc. Methods and systems for producing aav particles
WO2021163357A2 (en) * 2020-02-13 2021-08-19 Tenaya Therapeutics, Inc. Gene therapy vectors for treating heart disease
EP4103214B1 (en) * 2020-02-13 2026-04-29 Tenaya Therapeutics, Inc. Gene therapy vectors for treating heart disease

Similar Documents

Publication Publication Date Title
JP2024545186A5 (enExample)
JP7707261B2 (ja) 筋疾患の治療のための改変aavカプシドポリペプチド
JP7374119B2 (ja) 減少した肝臓向性を有するAAV9とAAVrh74とのハイブリッド組換えアデノ随伴ウイルス血清型
JP2025179046A5 (enExample)
US20220331409A1 (en) Factor ix gene therapy
JP2024545183A5 (enExample)
JP2022500066A5 (enExample)
JP2021531752A5 (enExample)
JP2023524291A5 (enExample)
JP6573991B2 (ja) 血管性浮腫の治療としてのc1eiのアデノ随伴ウイルス介在性送達
JP2020518268A5 (enExample)
JP2024523707A5 (enExample)
JP2022530824A5 (enExample)
JP2025509828A5 (enExample)
JP2023534037A5 (enExample)
US20250041453A1 (en) Methods and compositions for treating bag-3 related cardiomyopathy with a viral vector
JP2019524090A5 (enExample)
JP2022512589A5 (enExample)
EP4444363A1 (en) Methods and compositions for treating mybpc3 related hypertrophic cardiomyopathy with a viral vector
JP2020527167A5 (enExample)
JP2018526994A5 (enExample)
JP2020510433A5 (enExample)
JP2024527742A5 (enExample)
WO2023108130A2 (en) Compositions comprising kozak sequences selected for enhanced expression
JP2024528997A (ja) 放射線誘発性唾液機能低下を予防するためのaqp1遺伝子療法